Literature DB >> 11687687

Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations.

J S Yu1, K W Kim, M S Park, S W Yoon.   

Abstract

PURPOSE: To document the computed tomographic (CT) findings of transcatheter arterial chemoembolization (TACE)-induced, localized bile duct injuries leading to portal vein branch obliteration in the liver and to elucidate the clinical implications with retrospective review of the authors' experiences.
MATERIALS AND METHODS: Follow-up CT scans obtained in 11 patients with TACE-induced intrahepatic bile duct dilatation were reviewed retrospectively to evaluate serial changes in the adjacent portal vein branches and hepatic parenchyma. Clinical data, including time between TACE and CT and serum alkaline phosphatase levels, also were analyzed.
RESULTS: Of 11 patients with marked (n = 8) or mild (n = 3), lobar (n = 4) or segmental (n = 7) bile duct dilatation with or without bile collection in the tissue sheaths of the Glisson capsule or hepatic parenchyma, nine (82%) had bile duct changes at the first CT follow-up, within 1 month after TACE. Marked narrowing or obliteration of the adjacent intrahepatic portal vein branches in 10 (91%) patients resulted in progressive atrophy of the corresponding hepatic parenchyma in nine (82%) at variable times after TACE. The serum alkaline phosphatase level increased to more than 200 U/L in eight (89%) of nine patients 1 month after TACE.
CONCLUSION: TACE-induced intrahepatic bile duct injury resulting in obliteration of the adjacent portal vein branch seems to be one cause of hepatic parenchymal atrophic changes after TACE.

Entities:  

Mesh:

Year:  2001        PMID: 11687687     DOI: 10.1148/radiol.2212010339

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Haemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolisation for hepatic malignancy: interpretation of imaging findings.

Authors:  J Chung; J-S Yu; J-J Chung; J H Kim; K W Kim
Journal:  Br J Radiol       Date:  2009-07-06       Impact factor: 3.039

2.  Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.

Authors:  Bruno C Odisio; Aaron Ashton; Yuanqing Yan; Wei Wei; Ahmed Kaseb; Michael J Wallace; Jean N Vauthey; Sanjay Gupta; Alda L Tam
Journal:  J Vasc Interv Radiol       Date:  2015-06-05       Impact factor: 3.464

3.  Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation.

Authors:  N Sasahira; M Tada; H Yoshida; R Tateishi; S Shiina; K Hirano; H Isayama; N Toda; Y Komatsu; T Kawabe; M Omata
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Transient hepatic attenuation difference (THAD) following transcatheter arterial chemoembolization for hepatic malignancy: changes on serial CT examinations.

Authors:  Sung Ho Hwang; Jeong-Sik Yu; Jin Chung; Jae-Joon Chung; Joo Hee Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

5.  Fatal bile duct necrosis: a rare complication of transcatheter arterial chemoembolization in a patient with endocrine hepatic metastasis.

Authors:  Anne-Laure Pelletier; Pascal Hammel; Magali Zappa; Pierre Bedossa; Vinciane Rebours; Olivia Hentic; Frédérique Maire; Philippe Levy; Philippe Ruszniewski
Journal:  Case Rep Gastroenterol       Date:  2008-11-05

6.  Hepatocellular carcinoma after transcatheter arterial chemoembolization: difficulties on imaging follow-up.

Authors:  Jeong Sik Yu
Journal:  Korean J Radiol       Date:  2005 Jul-Sep       Impact factor: 3.500

7.  Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma.

Authors:  Jun-Hui Sun; Chun-Hui Nie; Yue-Lin Zhang; Guan-Hui Zhou; Jing Ai; Tan-Yang Zhou; Tong-Yin Zhu; Ai-Bin Zhang; Wei-Lin Wang; Shu-Sen Zheng
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

8.  Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model.

Authors:  Yong Wang; Bin Xiong; Bin Liang; Hui Zhao; Hui Li; Jun Qian; Hui-Min Liang; Gan-Sheng Feng; Chuan-Sheng Zheng
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

Authors:  Danny Ngo; Jemianne Bautista Jia; Christopher S Green; Anjalie T Gulati; Chandana Lall
Journal:  Insights Imaging       Date:  2015-10-06

10.  The Risk Assessment and Clinical Research of Bile Duct Injury After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.

Authors:  Houyun Xu; Xiping Yu; Jibo Hu
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.